ECDC's Monday tally: eight provinces, and the follow-up rate still short

As of 18 October the European centre counted 9,455 confirmed Bundibugyo cases and 4,561 deaths in Congo, with Nord Ubangi newly listed. Contact follow-up remains the dull lever that decides the map.

Health & Care Dr. Benjamin Koch / The Desk Monday, 19 October 2026, 17:43 CEST 2 min read1 sources

ECDC refreshed its Congo Bundibugyo page on Monday afternoon¹. As of 18 October (data to 17 October) it reported 9,455 confirmed cases and 4,561 related deaths; 925 patients hospitalised in isolation; 2,530 recoveries among those who tested positive¹. Since the previous ECDC update on 16 October (data to 14 October), an additional 178 confirmed cases and 83 deaths had been recorded¹.

Nord Ubangi is now listed: two confirmed cases from Wapinda health zone, bringing affected provinces to eight¹. Ituri remains by far the heaviest burden (6,918 cases); 66 of 178 health zones across the eight provinces are affected¹. About 80% of identified case contacts were under follow-up¹ — still short of the response’s own 95% discipline that this morning’s edition underlined from Congo’s SitRep.

The constructive habit is unchanged: watch the follow-up rate and the laboratory throughput, not only the shaded map. An eighth province is serious. A contact seen today is how a ninth is avoided.

What to watch

Tomorrow's ECDC weekday refresh and Congo's next SitRep PDF.
Contact follow-up share versus the 95% operational target.
Whether Nord Ubangi stays at two cases or seeds a ninth health-zone cluster.

Desk comment

A new province on a map is a logistics problem. Follow-up is how you shrink it.

Sources

Ebola disease outbreak in the Democratic Republic of the Congo — ECDC, updated 19 Oct 2026, 14:35.

Every figure in this piece traces to a source above or to the desk’s own arithmetic on those sources, marked as such. Quotations are short and attributed. Spot an error? Write to the desk; corrections are logged on the method page.

Commentary for information only. Not investment, legal, tax, medical or political advice. Not an offer or solicitation. Analysis may be incomplete or wrong. Charts show published public data, not a trading feed; binding numbers live with the institutions that publish them.